Compare ONCO & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ONCO | LCFY |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3M | 5.9M |
| IPO Year | 2021 | N/A |
| Metric | ONCO | LCFY |
|---|---|---|
| Price | $0.49 | $4.62 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 506.7K | 31.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,524,116.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4217.31 | N/A |
| 52 Week Low | $0.05 | $2.50 |
| 52 Week High | $7.65 | $13.98 |
| Indicator | ONCO | LCFY |
|---|---|---|
| Relative Strength Index (RSI) | 30.30 | 64.58 |
| Support Level | $0.07 | $3.92 |
| Resistance Level | $1.87 | $4.81 |
| Average True Range (ATR) | 0.12 | 0.38 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 0.82 | 88.86 |
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
Locafy Ltd is an Australian company currently focused on commercializing its Software as a Service (SaaS) online marketing technology (Technology), which prominently delivers a cost-effective location-based digital marketing solution for small businesses in the key markets of the USA, Australia and Canada. The company has two operating segments: Publishing and SEO Agency. The company derives the majority of its revenue from license subscription fees and advertising fees. Geographically, the maximum revenue is derived from North America.